Sekisui House

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – BATL, MDC, KNTE, INBX

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Key Points: 
  • NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.
  • Under the terms of the agreement, BATL shareholders are expected to receive $9.80 in cash per share they own.
  • Under the terms of the agreement, MDC shareholders are expected to receive $63.00 in cash per share they own.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you recover money for shareholders?

INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – SCTL, MDC, BATL, AVRO

Retrieved on: 
Friday, March 1, 2024

Under the terms of the agreement, SCTL shareholders are expected to receive $1.10 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, SCTL shareholders are expected to receive $1.10 in cash per share they own.
  • Under the terms of the agreement, MDC shareholders are expected to receive $63.00 in cash per share they own.
  • Under the terms of the agreement, AVRO shareholders are expected to own approximately 22.3% of the combined company.
  • Before you hire a law firm, you should talk to a lawyer and ask:
    Do you recover money for shareholders?

M.D.C. HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of M.D.C. Holdings, Inc. - MDC

Retrieved on: 
Wednesday, February 7, 2024

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of M.D.C. Holdings, Inc. (NYSE: MDC) to Sekisui House, Ltd.

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of M.D.C. Holdings, Inc. (NYSE: MDC) to Sekisui House, Ltd.
  • Under the terms of the proposed transaction, shareholders of M.D.C. will receive $63.00 in cash for each share of M.D.C. that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)

Retrieved on: 
Friday, January 26, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, Rover will be acquired by private equity funds managed by Blackstone in an all-cash transaction valued at approximately $2.3 billion.
  • Under the terms of the agreement, Rover stockholders will receive $11.00 per share in cash for each share of Rover they own.
  • Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – MDC, HARP, CVLY, AXNX

Retrieved on: 
Wednesday, January 24, 2024

Under the terms of the agreement, MDC shareholders are expected to receive $63.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, MDC shareholders are expected to receive $63.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, HARP shareholders will receive $23.00 in cash per share they own.
  • Under the terms of the agreement, AXNX shareholders will receive $71.00 in cash per share they own.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)

Retrieved on: 
Monday, January 22, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, Rover will be acquired by private equity funds managed by Blackstone in an all-cash transaction valued at approximately $2.3 billion.
  • Under the terms of the agreement, Rover stockholders will receive $11.00 per share in cash for each share of Rover they own.
  • Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder.

STOCKHOLDER ALERT: Juan Monteverde Encourages the Shareholders of TCN, KAMN, MDC, TARO to Take Action

Retrieved on: 
Saturday, January 20, 2024

Under the terms of the agreement, TCN shareholders are expected to receive $11.25 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, TCN shareholders are expected to receive $11.25 in cash per share they own.
  • Under the terms of the agreement, KAMN shareholders are expected to receive $46.00 in cash per share they own.
  • Taro Pharmaceutical Industries Ltd. (NYSE: TARO ), relating to its proposed sale to Sun Pharmaceutical Industries Ltd.
  • Under the terms of the agreement, TARO shareholders are expected to receive $43.00 in cash per share they own.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PG

Retrieved on: 
Thursday, January 18, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, MDC will be acquired by Sekisui House, Ltd. (“Sekisui House”).
  • MDC shareholders will receive $63.00 per share in cash in a deal with an equity value of $4.9 billion.
  • Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder.

M.D.C. Holdings Cancels 2023 Fourth Quarter Earnings Release Conference Call

Retrieved on: 
Monday, January 22, 2024

DENVER, Jan. 22, 2024 /PRNewswire/ -- M.D.C. Holdings, Inc. (NYSE: MDC), today announced that it will no longer hold its 2023 fourth quarter earnings conference call originally scheduled for Tuesday, January 30, 2024, at 12:30 p.m. Eastern Time.

Key Points: 
  • DENVER, Jan. 22, 2024 /PRNewswire/ -- M.D.C. Holdings, Inc. (NYSE: MDC), today announced that it will no longer hold its 2023 fourth quarter earnings conference call originally scheduled for Tuesday, January 30, 2024, at 12:30 p.m. Eastern Time.
  • As previously announced on January 18, 2024, MDC has entered into a definitive agreement to be acquired by a wholly-owned subsidiary of Sekisui House in an all-cash transaction.
  • MDC will issue its 2023 fourth quarter earnings press release as planned on January 30, 2024, before the market opens.

Exquisite Hillhaven Condominium by Far East Organization and Sekisui House Set to Launch in Late 2023

Retrieved on: 
Tuesday, December 12, 2023

SINGAPORE, Dec. 11, 2023 /PRNewswire-PRWeb/ -- Far East Organization and Sekisui House, two respected names in the real estate industry, are thrilled to announce the exclusive launch of Hillhaven, a sophisticated development that sets a new benchmark for luxury living in Singapore. Scheduled for release in late 2023, Hillhaven stands as a testament to the developers' commitment to excellence and innovation in residential design.

Key Points: 
  • Scheduled for release in late 2023, Hillhaven stands as a testament to the developers' commitment to excellence and innovation in residential design.
  • Hillhaven offers a luxurious residential experience with elegantly crafted tropical designs, generously spaced building blocks and opulent finishes.
  • The condominium offers a range of 1 to 4-bedroom layouts, ensuring a perfect fit for a diverse array of residents.
  • The collaboration between Far East Organization and Sekisui House, recipients of the prestigious FIABCI World Prix d'Excellence Awards 2020, guarantees a development that exceeds expectations.